which drugs are semaglutide The Boom in New Weight Loss Drugs: What Prehospital Caregivers Need to Know Semaglutide vs. Other GLP-1 Receptor

GLP-1 drugs are set to dominate 2024, with projected annual sales nearing $50 billion

Wegovy, a semaglutide-based weight loss treatment, shares some side effects with Ozempic, which is used for diabetes management

TENDON/LIGAMENT REPAIR Tendinous Effects (Emerging Studies): Collagen synthesis: increased matrix deposition 30% Fibrillar organization: improves collagen fiber alignment Vascularization: increased vascular density in the repair zone Biomechanical properties: improved tensile strength 25% Possible Mechanism: Modulation of local tendon cell metabolism Anti-inflammatory effects reduce the degradative phase Blood perfusion optimization (vascular lipid metabolism) ADVANCED RESEARCH PROTOCOLS Dosage Experimental Models Rodents (Mice/Rats): Large Models (Rabbits/Pigs): Non-Human Primates Lipolytic Optimization Protocols Circadian Timing Administration in the morning on an empty stomach: Maximum lipolysis 30-60 minutes before the first meal Synergy with low insulin levels Optimized FA Oxidation Pre-workout Effective alternative 15-30 minutes before aerobic activity FA mobilization as fuel Increase in energy consumption Cycle Protocols Continue: 6 days ON / 1 day OFF (prevents adaptation) Intermittent: 4 weeks ON / 2 weeks OFF (extended studies) Charging/Maintenance: Double dose weeks 1-2, then standard dose In Vitro Studies Primary Adipocytes/3T3-L1: Concentration: 10-100 g/mL (typically 50 g/mL) Lipolysis: glycerol release measurement 4-6h Gene expression: HSL, ATGL, perilipin (RT-qPCR) Phosphorylation of proteins: Western blot HSL-Ser563 Morphology: Analysis of Adipocyte Size (Oil Red O) Articular Chondrocytes Concentration: 10-50 g/mL Proteoglycan synthesis: 35S-sulfate incorporation Type II Collagen: Western Blot, Immunofluorescence GAGs: Dimethylmethylene Blue (DMMB) Assay Inflammation: IL-1-induced, MMP measurement Primary Hepatocytes Concentration: 25-100 g/mL Lipogenesis: incorporation of C-acetate into lipids Beta-Oxidation: Production of CO from Palmitate Triglyceride Accumulation: Colorimetric Assay Gene expression: FAS, ACC, CPT-1 (RT-qPCR) OPTIMIZED RECONSTITUTION METHODS AOD-9604 Reconstitution Protocol: Initial Preparation: Reconstitute lyophilized vial at room temperature for 10-15 minutes Disinfect the rubber cap with isopropyl alcohol 70% Prepare sterile area (laminar flow hood ideal) Diluent Selection Preferred Sterile bacteriostatic water (0.9% benzyl alcohol) Alternative Sterile 0.9% NaCl saline solution pH: 6.5-7.5 (outside range may degrade peptide) Temperature: ambient (68-77F) Recommended Concentrations: Vial 2mg: Add 2.0 mL 1 mg/mL (1000 g/mL) Vial 5mg: Add 5.0mL 1mg/mL Vial 10mg: Add 10.0mL 1mg/mL For precise dosing: consider lower concentrations (e.g., 5mg in 10mL 0.5mg/mL) Reconstitution Technique Insert 22-25G needle at a 45 angle against the vial wall Inject SLOWLY (45-60 seconds) directing flow to the wall CRITIC: Do not inject directly onto lyophilized powder Remove needle, rotate vial GENTLY in a circular motion Do not shake vigorously not to invest repeatedly Dissolution time: 1-3 minutes typically Let rest for 2-3 minutes to remove microbubbles Quality Check: The solution must be transparent and colorless Without visible particles, aggregates, or precipitation Without turbidity or color change Discard if there are any visual anomalies Storage and Stability: Critical Considerations Stability: Moderate photosensitivity: Protect from direct light (amber vials recommended) Temperature sensitivity Avoid prolonged periods above 25C Freeze-thaw: Maximum of 2 cycles (activity loss of ~25% per cycle) Defrost Slow thaw in the refrigerator at 4C overnight (never microwave/hot water bath) Temperature balance Allow 10-15 minutes at room temperature before SC administration RESEARCH FAQ Does AOD-9604 cause GH-like effects (growth, IGF-1)

Diabetologia 56: 2688-2696, 2013

If your normal is crappy and it brings you back to normal, youre going to feel like youve improved your performance but really youve gone from negative one to zero. The issue is that when people hear that it helps with energy production, they take that to mean its a stimulant

Your body is simultaneously adapting to losing the GIP receptor stimulation from tirzepatide while increasing GLP-1 stimulation from semaglutide